Company
Guernsey
£628.0 Million
GBP as of Jan. 1, 2025
US$788.1 Million
| Company | Market Cap (USD) |
|---|---|
| Blackstone | $225.01 B |
| BlackRock | $157.63 B |
| KKR & Co. Inc. | $97.78 B |
| Apollo Global Management, Inc. | $96.05 B |
| Brookfield Corporation | $87.47 B |
| Company | Market Cap (USD) |
|---|---|
| Berkshire Hathaway | $991.39 B |
| JPMorgan | $744.02 B |
| Visa | $635.57 B |
| Mastercard | $490.32 B |
| Bank of America | $353.07 B |
Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.
| Last Financial Reports Date | March 31, 2023 |
| Revenue TTM | £-144,462,000 |
| EBITDA | £0 |
| Gross Profit TTM | £0 |
| Profit Margin | 0.00% |
| Operating Margin | 131.43% |
| Quarterly Revenue Growth | % |
Syncona Limited has the following listings and related stock indices.
Stock: LSE: SYNC wb_incandescent